Showing results (151-160 of 286) with videos related to
Sort By:
Pageof 29
Diabetes Research and Clinical Practice|November 1, 1987
Hormonal and metabolic responses in brittle diabetic patients during feedback intravenous insulin infusionM Massi Benedetti, P D Home, G V Gill, et al.Diabetes, Obesity & Metabolism|February 3, 2015
New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3)G B Bolli, M C Riddle, R M Bergenstal, et al.Diabetes Research (Edinburgh, Scotland)|November 1, 1984
The response of blood intermediary metabolite levels to 24 hours treatment with a blood glucose-controlled insulin infusion system in type 1 diabetesB Capaldo, P D Home, M Massi-Benedetti, et al.Diabetologia|September 1, 1982
The metabolic and hormonal response to acute normoglycaemia in type 1 (insulin-dependent) diabetes: studies with a glucose controlled insulin infusion system (artificial endocrine pancreas)R Nosadini, G A Noy, M Nattrass, et al.Diabetes, Obesity & Metabolism|April 8, 2015
One-year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal-time insulin: the EDITION 1 12-month randomized trial, including 6-month extensionM C Riddle, H Yki-Järvinen, G B Bolli, et al.Diabetes Research (Edinburgh, Scotland)|September 1, 1985
A prospective study of the immunogenicity of porcine insulin in HLA-typed new insulin-treated diabeticsL O Almér, G Ekberg, S Fankhauser, et al.Drug Safety|January 1, 1996
Cyproterone acetate: is it hepato- or genotoxic?T Rabe, K Feldmann, L Heinemann, et al.Diabetes Care|August 1, 1992
Severe hypoglycemia incidence and predisposing factors in 85 pregnancies of type I diabetic womenR Kimmerle, L Heinemann, A Delecki, et al.Diabete & Metabolisme|January 1, 1992
Pharmacokinetics and pharmacodynamics of subcutaneously administered U40 and U100 formulations of regular human insulinL Heinemann, E A Chantelau, A A StarkeDiabetic Medicine : a Journal of the British Diabetic Association|April 17, 1998
The blood glucose lowering effects of exercise and glibenclamide in patients with type 2 diabetes mellitusU Gudat, S Bungert, F Kemmer, et al.Pageof 29